Re: Vickers et al: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening (Urology 2016; 91: 12-18)

被引：0
|
作者：
Shah, Navin [1 ]
Ioffe, Vladimir [2 ]
机构：
[1] Midatlantic Urol Associates, Greenbelt, MD 20770 USA
[2] 21st Century Oncol, Greenbelt, MD USA
来源：
UROLOGY | 2016年 / 95卷
关键词：
AGE;
D O I：
10.1016/j.urology.2016.05.049
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [41] Re: Fascelli et al: Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population (Urology 2016;88:125-134)
    Sertkaya, Zulfu
    UROLOGY, 2016, 95 : 223 - 223
  • [42] Re: Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade, et al. The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010;58:574-580
    Chung, Shiu-Dong
    Wang, Shuo-Meng
    Chueh, Shih-Chieh
    EUROPEAN UROLOGY, 2011, 59 (01) : E2 - E2
  • [43] Re: Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade et al. The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010;58:574-80
    Mouracade, Pascal
    EUROPEAN UROLOGY, 2011, 59 (04) : E23 - E23
  • [44] Re: Tollefson et al.: Serum Calcium Is Not Predictive of Aggressive Prostate Cancer After Radical Prostatectomy (Urology 2011;77:1161-1165)
    Schwartz, Gary G.
    Skinner, Halcyon G.
    UROLOGY, 2011, 77 (06) : 1511 - 1512
  • [45] Re: Kryvenko et al.: Prostate-specific Antigen Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution (Urology, 2016;90:141-147)
    Pishgar, Farhad
    UROLOGY, 2016, 90 : 228 - 229
  • [46] Re: Tollefson et al.: Serum Calcium Is Not Predictive of Aggressive Prostate Cancer After Radical Prostatectomy (Urology 2011;77:1161-1165) Reply
    Tollefson, Matthew K.
    Karnes, R. Jeffrey
    UROLOGY, 2011, 77 (06) : 1512 - 1512
  • [47] Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool
    Gandaglia, Giorgio
    Barletta, Francesco
    Robesti, Daniele
    Scuderi, Simone
    Rajwa, Pawel
    Rivas, Juan Gomez
    Ibanez, Laura
    Soeterik, Timo F. W.
    Bianchi, Lorenzo
    Afferi, Luca
    Kesch, Claudia
    Darr, Christopher
    Guo, Hongqian
    Zhuang, Junlong
    Zattoni, Fabio
    Fendler, Wolfgang
    Marra, Giancarlo
    Stabile, Armando
    Amparore, Daniele
    Huebner, Nicolai A.
    Giesen, Alexander
    Joniau, Steven
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Mattei, Agostino
    Dal Moro, Fabrizio
    Sierra, Jesus Moreno
    Porpiglia, Francesco
    Picchio, Maria
    van den Bergh, Roderick
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (06): : 543 - 552
  • [48] Re: Kryvenko et al.: Prostate-specific Antigen Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution (Urology, 2016;90:141-147) Reply
    Kryvenko, Oleksandr N.
    UROLOGY, 2016, 90 : 229 - 230
  • [49] Comparison of Risk of Ipsilateral Breast Event After Lumpectomy for Ductal Carcinoma In Situ, As Estimated by Breast Radiation Oncologists, Van Nuys Prognostic Index, Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-gene DCIS Score
    Lei, R. Y.
    Carter, D. L.
    Antell, A. G.
    Nowels, M. A.
    Fryman, S. P.
    Janotta, E.
    Leonard, C. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E45 - E45
  • [50] Re: Zhao et al.: External validation of University of California, San Francisco, cancer of the prostate risk assessment score (Urology 2008;72:396-400)
    Stephenson, Andrew J.
    UROLOGY, 2008, 72 (03) : 719 - 720
12345